GAD1 and lung cancer: We have found increase of serum glutamate concentrations in lung cancer patients with neurological deficit and upregulation of serum GAD activity in subjects with CNS symptoms, particularly with cerebellar syndrome, while serum GDH activity was downregulated in patients manifesting neurological symptoms.